Overview
A university analytical chemistry group running a peptide-synthesis research line needed a reference standard to anchor the purity of their own synthesized material. The group synthesizes short peptides in-house as part of a method-development research program and publishes the resulting analytical data in journals that require per-lot characterization of every standard cited.
The group evaluated elev8 Labs reference peptides across three of the sequences they synthesize. The evaluation ran for two academic semesters. This write-up describes how the lab integrated elev8 Labs material into their analytical workflow, what documentation they captured for publication, and which paperwork touchpoints closed the audit loop with the university's research-administration office.
The research context
The lab was refining an Fmoc solid-phase synthesis method. Their hypothesis concerned the relationship between resin loading and main-peak purity at scale. To report main-peak purity credibly, they needed an externally assayed reference standard for each sequence — a material their HPLC could identify and their mass spectrometer could verify — against which the in-house material could be compared.
The lab's requirement was specific. They needed:
- A reference peptide of the same sequence as the in-house synthesis.
- An independent laboratory verification of that reference's purity, documented per lot.
- Enough material per lot to run calibration and identity runs across several synthesis campaigns without re-sourcing mid-study.
- Lot traceability sufficient for the journal's materials-and-methods requirements.
Why elev8 Labs
The lab selected elev8 Labs reference peptides after comparing three vendors. The evaluation was explicit in the lab's purchase records:
- HPLC purity reported as main-peak area with a chromatogram attached. The chromatogram let the graduate student match peak shape, not just the numeric figure.
- Mass confirmation on the COA. The reported monoisotopic mass, matched against the expected sequence mass within typical mass-spec tolerance, closed the identity check.
- Lot retention policy disclosed. elev8 Labs commits to retaining each lot's COA for a multi-year window. The lab's journal submissions cite the lot number, and the group wanted assurance the reference could be re-verified years after publication.
- Shipment practice. Lyophilized material arrived sealed with a desiccant in a foam-insulated shipper, consistent with the storage guidance the lab follows for their own synthesized peptides.
Analytical workflow
The lab ran the following workflow with elev8 Labs material:
- Receipt and incoming QC. On arrival the graduate student photographed the COA, logged the lot number into the group's shared ELN, and stored the sealed reference at −20 °C until first use.
- Reference HPLC. A small aliquot was dissolved, injected on the lab's analytical HPLC, and the retention time + main-peak area recorded. The group's internal acceptance window (main-peak area within 0.5% of the elev8 Labs COA value) was met on every lot.
- Reference MS. The same aliquot was injected on a Q-TOF; the measured monoisotopic mass was within tolerance of the sequence mass. The mass confirmation was archived as a screenshot in the ELN.
- Synthesis comparison runs. In-house synthesized material was run against the elev8 Labs reference on the same HPLC, same day, identical solvent program. The main-peak purity of the in-house material was reported in the publication as a relative figure — always against the same reference.
- Publication-grade figures. Chromatograms for both the reference and the in-house material appeared in the journal submission. The materials-and-methods section cited elev8 Labs by name and by lot number.
The entire workflow happened at the analytical bench. No in-vivo study, no animal administration, no human-subject work. The group does not operate in those spaces and their IRB does not approve such work.
Outcomes observed
Three methodological outcomes tracked during the two-semester window:
- Publication timeline held. The two journal submissions filed during the evaluation did not bounce back with materials-and-methods requests. The editors and peer reviewers accepted the citation format without additional documentation requests.
- Student-onboarding time shortened. A new graduate student joining the synthesis line was productive on the reference-comparison workflow in a single training session. The COA served as the reference-handling SOP, reducing the need for verbal transfer of tacit knowledge.
- Audit preparation was tidy. During the university's routine research-administration inventory review, the group was asked to produce documentation for reference materials used in the prior year. A single PDF export from the ELN — one page per lot — satisfied the request.
None of these outcomes describe biological behavior of the peptides involved. The outcomes are analytical and administrative, which matches the question the lab set out to answer.
Audit trail
The university's research-administration office requires that every externally sourced chemical used in a sponsored research program be traceable to a source with documented specifications. elev8 Labs material satisfied this requirement because:
- The COA ships with the material and is archived against the purchase record in the lab's ELN.
- The vendor's order history surfaces the lot number for each shipment against the graduate student's account, so two independent references (ELN and vendor portal) agree on the lot cited in the publication.
- Re-verification is possible for the multi-year window the vendor retains the COA — a property the lab's principal investigator specifically checked during vendor evaluation.
References
The analytical methods referenced in this case study are standard peptide-chemistry literature: ICH Q2 on analytical-method validation, USP General Chapter on HPLC system suitability, and the journal's materials-and-methods requirements for peptide-synthesis publications. None of these references concern human or veterinary use of the peptides involved. The partner lab's research program is in-vitro analytical chemistry — method development, not pharmacology.
elev8 Labs products are reference standards for laboratory research only. Not for human consumption.